
Sign up to save your podcasts
Or


Today’s cancer therapies are difficult, expensive, and slow to create. But the combination of new computing and new biological technologies is leading to a better understanding of the human immune system, with the goal of offering a better class of cancer therapies.
Azeem Azhar speaks with Immunai co-founder and chief technology officer Luis Voloch about how AI is unlocking the secrets of the immune system and opening new avenues for novel cancer treatments.
They also discuss:
@Azeem
Further resources:
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By Azeem Azhar4.9
606606 ratings
Today’s cancer therapies are difficult, expensive, and slow to create. But the combination of new computing and new biological technologies is leading to a better understanding of the human immune system, with the goal of offering a better class of cancer therapies.
Azeem Azhar speaks with Immunai co-founder and chief technology officer Luis Voloch about how AI is unlocking the secrets of the immune system and opening new avenues for novel cancer treatments.
They also discuss:
@Azeem
Further resources:
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

390 Listeners

2,690 Listeners

1,089 Listeners

167 Listeners

195 Listeners

3,990 Listeners

1,377 Listeners

745 Listeners

1,249 Listeners

168 Listeners

201 Listeners

511 Listeners

494 Listeners

261 Listeners

63 Listeners

676 Listeners

131 Listeners

35 Listeners

40 Listeners